MetLife Statistics
Total Valuation
MetLife has a market cap or net worth of $59.90 billion. The enterprise value is $85.34 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Feb 4, 2025 |
Share Statistics
MetLife has 692.42 million shares outstanding. The number of shares has decreased by -6.67% in one year.
| Current Share Class | 692.42M |
| Shares Outstanding | 692.42M |
| Shares Change (YoY) | -6.67% |
| Shares Change (QoQ) | -1.54% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 75.39% |
| Float | 576.53M |
Valuation Ratios
The trailing PE ratio is 17.57 and the forward PE ratio is 9.42. MetLife's PEG ratio is 0.69.
| PE Ratio | 17.57 |
| Forward PE | 9.42 |
| PS Ratio | 0.87 |
| Forward PS | 0.78 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | 3.95 |
| P/OCF Ratio | 3.95 |
| PEG Ratio | 0.69 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.13, with an EV/FCF ratio of 5.63.
| EV / Earnings | 23.96 |
| EV / Sales | 1.20 |
| EV / EBITDA | 12.13 |
| EV / EBIT | 13.52 |
| EV / FCF | 5.63 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 1.51.
| Current Ratio | 1.59 |
| Quick Ratio | 1.35 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | 6.52 |
| Debt / FCF | 3.11 |
| Interest Coverage | 6.03 |
Financial Efficiency
Return on equity (ROE) is 13.26% and return on invested capital (ROIC) is 3.73%.
| Return on Equity (ROE) | 13.26% |
| Return on Assets (ROA) | 0.58% |
| Return on Invested Capital (ROIC) | 3.73% |
| Return on Capital Employed (ROCE) | 0.96% |
| Revenue Per Employee | $1.59M |
| Profits Per Employee | $79,133 |
| Employee Count | 45,000 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MetLife has paid $1.40 billion in taxes.
| Income Tax | 1.40B |
| Effective Tax Rate | 27.00% |
Stock Price Statistics
The stock price has increased by +22.17% in the last 52 weeks. The beta is 1.06, so MetLife's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +22.17% |
| 50-Day Moving Average | 84.02 |
| 200-Day Moving Average | 77.51 |
| Relative Strength Index (RSI) | 57.71 |
| Average Volume (20 Days) | 3,502,541 |
Short Selling Information
The latest short interest is 7.40 million, so 1.07% of the outstanding shares have been sold short.
| Short Interest | 7.40M |
| Short Previous Month | 6.50M |
| Short % of Shares Out | 1.07% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, MetLife had revenue of $71.34 billion and earned $3.56 billion in profits. Earnings per share was $4.92.
| Revenue | 71.34B |
| Gross Profit | 18.24B |
| Operating Income | 6.31B |
| Pretax Income | 3.69B |
| Net Income | 3.56B |
| EBITDA | 7.04B |
| EBIT | 6.31B |
| Earnings Per Share (EPS) | $4.92 |
Full Income StatementBalance Sheet
The company has $29.80 billion in cash and $47.20 billion in debt, giving a net cash position of -$25.44 billion or -$36.74 per share.
| Cash & Cash Equivalents | 29.80B |
| Total Debt | 47.20B |
| Net Cash | -25.44B |
| Net Cash Per Share | -$36.74 |
| Equity (Book Value) | 31.16B |
| Book Value Per Share | 44.53 |
| Working Capital | 27.36B |
Full Balance SheetCash Flow
| Operating Cash Flow | 15.17B |
| Capital Expenditures | n/a |
| Free Cash Flow | 15.17B |
| FCF Per Share | $21.91 |
Full Cash Flow StatementMargins
Gross margin is 25.57%, with operating and profit margins of 8.85% and 5.27%.
| Gross Margin | 25.57% |
| Operating Margin | 8.85% |
| Pretax Margin | 7.26% |
| Profit Margin | 5.27% |
| EBITDA Margin | 9.86% |
| EBIT Margin | 8.85% |
| FCF Margin | 21.26% |